Tag:
EKR Therapeutics
Latest Headlines
Latest Headlines
C&L: Bethune tapped as interim Zila CEO
Zila Chairman David Bethune is taking on the role of acting CEO. That post has been empty since last June, when Doug Burkett left the job. Barr Pharmaceuticals announced the following promotions:
Genmab buys antibody plant in $240M deal
PDL BioPharma has inked a deal to sell its U.S. antibody manufacturing plant to Denmark's Genmab for $240 million. The deal--which will enable Genmab to transition three
